QCM Cayman’s iShares Biotechnology ETF IBB Stock Holding History

QCM Cayman’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,700	Closed	-$366K	–	293
2020 Q3	$366K	Buy	2,700 +1,051	+64%	+$143K	0.64%	42
2020 Q2	$225K	Buy	+1,649	New	+$210K	0.51%	85
2016 Q4	–	Sell	-2,826	Closed	-$273K	–	202
2016 Q3	$273K	Buy	+2,826	New	+$269K	0.3%	90
2015 Q2	–	Sell	-2,268	Closed	-$260K	–	216
2015 Q1	$260K	Sell	2,268 -33	-1%	-$3.64K	0.14%	132
2014 Q4	$233K	Buy	+2,301	New	+$224K	0.1%	169
2014 Q2	–	Sell	-4,431	Closed	-$349K	–	284
2014 Q1	$349K	Buy	+4,431	New	+$369K	0.08%	147

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

QCM Cayman's IBB Position: Q4 2020 in Review

QCM Cayman sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 2,700 shares — an estimated $366K sold.

QCM Cayman first reported a position in IBB in Q1 2014 and held it in 6 quarters. The position peaked at $366K in Q3 2020. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

QCM Cayman reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
QCM Cayman sold 2,700 iShares Biotechnology ETF shares in Q4 2020, an estimated $366K.
QCM Cayman first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 6 quarters.
QCM Cayman's iShares Biotechnology ETF position peaked at $366K in Q3 2020.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on QCM Cayman's 13F filing for Q4 2020, filed 12 Feb 2021.